Table 1.
Baseline characteristics of study participants
|
| |||
| Characteristic | With metabolic syndrome median (range) | Without metabolic syndrome median (range) | |
| Age, years | 30 (19-41) | 32 (18-44) | |
| BMI, kg/m | 28.89 (21.90-38.86) | 26.34 (17.40-44.33) | |
| Waist circumference, cm | 86.0 (79.0-103.0) | 82.5 (57.0-114.0) | |
| Systole, mmHg | 127 (102-150) | 111 (93-135) | |
| Diastole, mmHg | 83 (70-100) | 73 (60-94) | |
| Fasting blood glucose, mg/dL | 96 (68-271) | 86 (68-132) | |
| Triglyceride, mg/dL | 169 (83-473) | 95 (41-156) | |
| HDL, mg/dL | 40 (21-51) | 48 (26-64) | |
| FG Index | |||
| 5 | 4 (36.4%) | 7 (63.6%) | |
| 5 | 14 (22.6%) | 48 (77.4%) | |
| PCOs phenotype | |||
| 1: OA + HA + PCOM | 13 (56.5%) | 23 (26.7%) | |
| 2: OA + HA | 1 (4.4%) | 11 (12.8%) | |
| 3: PCOM + HA | 1 (4.4%) | 15 (17.4%) | |
| 4: OA + PCOM | 8 (34.7%) | 37 (43.1%) | |
| BMI: Body mass index; HDL: High-density lipoprotein; FG: Ferriman-Gallwey; OA: Oligo- or anovulation; HA: Hyperandrogenism; PCOM: Polycystic ovary morphology | |||